欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/1539/003
药品名称Lamictal Dispers 25 mg,kauw/dispergeerbare tabletten
活性成分
    • lamotrigine 25.0 mg
剂型Chewable/dispersible tablet
上市许可持有人GlaxoSmithKline BV Van Asch van Wijckstraat 55H 3811 LP Amersfoort The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      Lamictal 25 mg - lösliche Tabletten
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Portugal (PT)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Cyprus (CY)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Czechia (CZ)
    • Estonia (EE)
    • Bulgaria (BG)
许可日期2008/09/25
最近更新日期2024/04/22
药物ATC编码
    • N03AX09 lamotrigine
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase